182 related articles for article (PubMed ID: 35837113)
1. The Diagnostic Potential of
Gao H; Yang J; He L; Wang W; Liu Y; Hu Y; Ge M; Ding J; Ye Q
Front Oncol; 2022; 12():849024. PubMed ID: 35837113
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of RASSF1A and SHOX2 methylation combined with EGFR mutations for differentiation between small pulmonary nodules.
Ji XY; Li H; Chen HH; Lin J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8557-8571. PubMed ID: 37097393
[TBL] [Abstract][Full Text] [Related]
3. The combination of SHOX2 and RASSF1A DNA methylation had a diagnostic value in pulmonary nodules and early lung cancer.
Xie B; Dong W; He F; Peng F; Zhang H; Wang W
Oncology; 2024 Jan; ():. PubMed ID: 38262380
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of exfoliated tumor cells combined with DNA methylation in bronchoalveolar lavage fluid for lung cancer.
Lu H; Lin D
Medicine (Baltimore); 2023 Sep; 102(36):e34955. PubMed ID: 37682182
[TBL] [Abstract][Full Text] [Related]
5. DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis.
Zhang C; Yu W; Wang L; Zhao M; Guo Q; Lv S; Hu X; Lou J
J Cancer; 2017; 8(17):3585-3591. PubMed ID: 29151944
[No Abstract] [Full Text] [Related]
6. Analysis of the Prognostic Value and Gene Expression Mechanism of
Li N; Zeng Y; Tai M; Lin B; Zhu D; Luo Y; Ren X; Zhu X; Li L; Wu H; Huang J
Front Mol Biosci; 2021; 8():688274. PubMed ID: 34262939
[No Abstract] [Full Text] [Related]
7. Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer.
Li N; Zeng Y; Huang J
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1379-1393. PubMed ID: 32266538
[TBL] [Abstract][Full Text] [Related]
8. Combined Methylation of
Zhong Q; Wang Y; Liang C; Wei F; She B
Discov Med; 2023 Oct; 35(178):845-852. PubMed ID: 37811622
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of SHOX2, RASSF1A gene methylation combined with CEA level detection in malignant pleural effusion.
Chen S; Huang K; Zou L; Chen L; Hu P
BMC Pulm Med; 2023 May; 23(1):160. PubMed ID: 37158875
[TBL] [Abstract][Full Text] [Related]
10. Performance Evaluation of
Shi J; Chen X; Zhang L; Fang X; Liu Y; Zhu X; Zhang H; Fan L; Gu J; Zhang S; She B; Han H; Yi X
Front Oncol; 2020; 10():565780. PubMed ID: 33425721
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the comprehensive diagnosis efficiency of lung cancer, including measurement of SHOX2 and RASSF1A gene methylation.
Liu J; Bian T; She B; Liu L; Sun H; Zhang Q; Zhu J; Zhang J; Liu Y
BMC Cancer; 2024 Mar; 24(1):282. PubMed ID: 38429660
[TBL] [Abstract][Full Text] [Related]
12. Performance of SHOX2 and RASSF1A methylation assay in supernatants and matched cell pellets for the diagnosis of malignant pleural effusion.
Zhang N; Li Y; Zhang H; Dong Y; Zhang C; Du W; Long C; Xing X; Li K; Liu Z; Chen X; Zhang L; Xu F; Fu Y; Tan J; She B; Che N
Clin Chim Acta; 2024 Jan; 553():117699. PubMed ID: 38072300
[TBL] [Abstract][Full Text] [Related]
13. DNA Methylation Analysis of the
Zhang N; Liu Z; Li K; Xing X; Long C; Liu F; She B; Che N
J Oncol; 2023; 2023():5888844. PubMed ID: 36691467
[TBL] [Abstract][Full Text] [Related]
14. Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis.
Ilse P; Biesterfeld S; Pomjanski N; Wrobel C; Schramm M
Cancer Genomics Proteomics; 2014; 11(5):251-8. PubMed ID: 25331797
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive diagnostic scheme of morphological combined molecular methylation under bronchoscopy.
Zhang J; Huang H; Yu F; Bian Y; Wang R; Liu H; Kang S; She B; Shi Z
Front Oncol; 2023; 13():1133675. PubMed ID: 37182143
[TBL] [Abstract][Full Text] [Related]
16. Short stature homeobox 2 methylation as a potential noninvasive biomarker in bronchial aspirates for lung cancer diagnosis.
Ni S; Ye M; Huang T
Oncotarget; 2017 Sep; 8(37):61253-61263. PubMed ID: 28977861
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of unmethylated RASSF1A on disease progression in non-small cell lung cancer patients receiving pemetrexed-based chemotherapy.
Deng Q; Su B; Ji X; Fang Q; Zhou S; Zhou C
Cancer Biomark; 2020; 27(3):313-323. PubMed ID: 31839603
[TBL] [Abstract][Full Text] [Related]
18. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
[TBL] [Abstract][Full Text] [Related]
19. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of
Branchi V; Schaefer P; Semaan A; Kania A; Lingohr P; Kalff JC; Schäfer N; Kristiansen G; Dietrich D; Matthaei H
Clin Epigenetics; 2016; 8():133. PubMed ID: 27999621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]